Biosensors for single cell and multi cell analysis

• US 20030104512A1
• Filed: 11/30/2001
• Published: 06/05/2003
• Est. Priority Date: 11/30/2001
• Status: Abandoned Application

• Current Assignee: Cytoplex Biosciences Incorporated
• Original Assignee: Cytoplex Biosciences Incorporated
• Inventors: Wilk-Blaszczak, Malgosia, Freeman, Alex R.
• Application Number:
  US10/013,017
• Publication Number:
  US 20030104512A1
• Time in Patent Office: Days
• US Class Current: 435/29
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions
• CPC Class Codes: G01N 33/5005 involving human or animal cells immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025
• CPC Class Codes: G01N 33/6872 Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Abstract

The present invention relates to a structure comprising a biological membrane and substrate with fluidic network, an array of membranes and an array of fluidic networks in substrate, a high throughput screen, methods for production of the membrane, substrate structure, and a method for interconnected array of substrate structures and a method for attaching membranes to structure, a method to electrically record events from the membranes and a method to screen large compound library using the array. More particularly, it relates to biological cells and artificial cell membranes adhered to the substrate with a high electrical resistivity seal, a method to manufacture array configuration of such substrates, and a method to screen compounds using the membrane receptors such as ion-channels, ion pumps, & receptors.

Claims

1. A structure comprising:

a substrate having a microfluidic channel;

a substrate membrane disposed over the substrate and in fluidic connection with the microfluidic channel, and further having at least one opening operable to allow passage of molecules having a set of predetermined characteristics;

first and second electrodes disposed on both sides of the substrate membrane operable to detect molecular transport across the substrate membrane and a biological substance deposited thereon.

2. The structure, as set forth in claim 1, wherein the at least one opening of the substrate membrane comprises a plurality of pores in the substrate membrane.

3. The structure, as set forth in claim 1, further comprising an electric field applied across the substrate membrane operable to displace a liquid retained on one side of the substrate membrane to the other side of the substrate membrane via the at least one opening.

4. The structure, as set forth in claim 1, where the biological substance is selected from the group consisting of individual cells, cells grown in a monolayer, tissue samples, artificial lipid bilayers with embedded proteins, cells from animals, plants and humans, miocites, ion-channel expressed oocytes, CHO cells, muscle cells, epithelia and immune cells.

5. The structure, as set forth in claim 1, where the biological substance further comprising a biological membrane having ion-channel proteins or transporter molecules and adhering to the at least one opening of the substrate membrane, making a tight electrical and fluidic seal.

6. The structure, as set forth in claim 1, wherein the substrate membrane comprises at least one opening operable to allow passage of molecules depending on their size, ionic charge and shape.

7. The structure, as set forth in claim 1, where the at least one opening of the substrate membrane comprises a microhole having a diameter ranging between 1 to 10 microns. inclusively

8. The structure, as set forth in claim 1, to measure impedance of cells positioned on the at least one opening.

9. The structure, as set forth in claim 7, to measure impedance of cells positioned on the microhole.

10. The structure, as set forth in claim 1, further comprising an array of openings formed in the substrate membrane disposed over an array of through holes formed in the substrate.

11. The structure, as set forth in claim 1, wherein the substrate membrane comprises a porous gel.

12. The structure, as set forth in claim 1, wherein the substrate membrane comprises glass frit.

13. The structure, as set forth in claim 1, wherein the substrate membrane comprises silicon nitride thin film.

14. The structure, as set forth in claim 5, wherein the substrate membrane further comprises a cell adhesion coating operable to promote adhesion of the biological membrane to the substrate membrane.

15. The structure, as set forth in claim 1, wherein the first and second electrodes are constructed of an ion-selective material or compound material selected from a group consisting of gold, platinum, and silver/silver chloride.

16. The structure, as set forth in claim 1, wherein the biological membrane is constructed of gland cells selected from a group consisting of pancreas, intestine, and gallbladder.

17. The structure, as set forth in claim 7, further comprising at least one micro-groove formed around the microhole.

18. The structure, as set forth in claim 7, further comprising 1 to 20 micro-grooves having 0.1 micron to 2 microns width and 0.1 micron to 1 micron depth formed around the microhole

19. The structure, as set forth in claim 7 or 18, wherein the substrate membrane further comprises a cell adhesion coating around the microhole and covering a diameter of 10 microns to 1000 microns.

20. The structure, as set forth in claim 10, further comprising an electromechanical force operable for steering an array of fluids into and out of the array of through holes in the substrate.

21. The structure, as set forth in claim 20, wherein the electromechanical force comprises at least one of an electrokinetic force and a vacuum force.

22. The structure, as set forth in claim 1, wherein at least one of the first and second electrodes is formed integrally on the substrate membrane.

51. A method according to claim 16, where the effect of secretion from the cells on the ion-channel kinetics is explored and the method of modifying the secretion with drugs is studied.

23. A method, comprising:

dispensing biological substance on a substrate membrane having predefined porosity, the substrate membrane being disposed over a substrate having a microfluidic channel in fluidic communication with the substrate membrane;

applying an electrical potential across the substrate membrane; and

detecting and measuring a charged species flux across the substrate membrane.

24. The method, as set forth in claim 23, where the biological substance is selected from the group consisting of individual cells, cells grown in a monolayer, tissue samples, artificial lipid bilayers with embedded proteins, cells from animals, plants and humans, miocites, ion-channel expressed oocytes, CHO cells, muscle cells, epithelia and immune cells.

25. The method, as set forth in claim 23, further comprising positioning at least one cell in a microhole formed in the substrate using electrokinetic fluid pumping.

26. The method, as set forth in claim 23, further comprising positioning at least one cell in a microhole formed in the substrate by applying a force selected from at least one of a large potential across the microhole and a vacuum.

27. The method, as set forth in claim 23, further comprising perforating a cell membrane that is positioned on the microhole by an applied force.

28. The method, as set forth in claim 23, further comprising perforating a cell membrane that is positioned on the microhole by applying at least one of an electric field and a vacuum across the microhole.

29. The method, as set forth in claim 25, further comprising supplying the at least one cell with ion-channel agonists or antagonists on either side of the cell membrane.

30. The method, as set forth in claim 25, further comprising transfecting the at least one cell with cDNA or cRNA encoding of ion channels of interest and cloning of cells.

31. The method, as set forth in claim 25, further comprising immersing the at least one cell in physiological solutions.

32. The method, as set forth in claim 25, further comprising optical incidence and optical detection of cells from either side of the substrate. The optical methods are any of exposing the biological substance to an optical source;

and detecting an optical property of the biological substance.

33. The method, as set forth in claim 25, further comprising applying an electrical potential to temporarily open the pores on the cell membrane.

34. The method, as set forth in claim 23, wherein measuring comprises measuring cell membrane conductance.

35. The method, as set forth in claim 23, wherein measuring comprises measuring cell membrane impedance.

36. The method, as set forth in claim 23, wherein measuring comprises measuring cell membrane ion channel current.

37. The method, as set forth in claim 23, wherein measuring comprises measuring cell-to-cell junction resistance.

38. The method, as set forth in claim 23, wherein dispensing biological cells comprises dispensing biological cells on an array of substrate membranes, the array of substrate membranes being disposed over a substrate having respective microfluidic channels in fluidic communication with the respective substrate membranes, and performing an array of tests with pharmacological compounds for the purpose of high throughput testing.

39. The method, as set forth in claim 23, further comprising positioning at least one cell in a microhole formed in the substrate by applying a large potential across the microhole using a pair of electrodes, measuring biological membrane to microhole seal resistance, and to vary the applied potential to adjust the position of the cells in response to the measured seal resistance.

40. The method, as set forth in claim 23, further comprising:

culturing retinal cells on the substrate membrane;

activating the cells with light; and

recording ion concentrations of sodium, potassium, calcium and chlorine.

41. The method, as set forth in claim 38, further comprising using a multiplexer coupled to the substrate to facilitate array-based high throughput drug screening.

42. The method, as set forth in claim 39, further comprising adjusting fluid flow in a throughhole formed in the substrate and in fluid communication with the microhole by applying a large potential across the microhole using a pair of electrodes, measuring biological membrane-to-microhole seal resistance, and to vary the applied potential to adjust the position of the cells in response to the measured seal resistance.

43. The method, as set forth in claim 42, further comprising:

measuring impedance across the throughhole; and

adjusting the fluid flow in each through hole of the array by varying the drive potential in an array in response to the measured impedance across the corresponding through hole.

44. The method, as set forth in claim 27, further comprising:

measuring impedance across the throughhole;

controlling the electric fields or suction fluid forces to perforate the cell membrane in response to the measured impedance across the throughhole.

45. A method of forming, comprising:

chemically depositing a thin film of thermal oxide and nitride on both sides with a first side of a substrate having an electronic circuit;

patterning the thin film on the second side of the substrate and using this patterned thin film as a mask;

creating an opening on the second side of the substrate to form a suspended thin film membrane on the first side allowing transmission of light there through;

forming an electrode pattern on the first side, the electrode pattern being coupled to the electronic circuit.

46. The method as claimed in 45, forming prior to forming an electrode pattern further comprising;

forming a second substrate on the patterned second side of the first substrate, thereby creating a microfluidic channel in fluid communication with the suspended membrane.

49. The method as claimed in claims 46, 47 and 48:

attaching the second substrate by gluing with adhesive agent.

50. The method as claimed in claims 46:

attaching the second substrate by heating and applying pressure on both first and second substrates.

47. The method as claimed in 45:

forming a second substrate on the patterned second side of the first substrate, thereby creating a microfluidic channel in fluid communication with the suspended membrane.

48. The method as claimed in 45:

forming an electrode pattern on the second side;

forming a second substrate on the patterned second side of the first substrate, thereby creating a microfluidic channel in fluid communication with the suspended membrane.